Romano Brothers & Co’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$211K Buy
954
+9
+1% +$2.49K 0.02% 327
2026
Q1
$279K Sell
945
-27
-3% -$8.02K 0.03% 292
2025
Q4
$265K Hold
972
0.03% 288
2025
Q3
$263K Hold
972
0.03% 295
2025
Q2
$268K Hold
972
0.03% 282
2025
Q1
$258K Buy
972
+27
+3% +$6.66K 0.03% 279
2024
Q4
$219K Hold
945
0.03% 288
2024
Q3
$209K Buy
+945
New +$196K 0.03% 300
2024
Q2
Sell
-3,845
Closed -$828K 303
2024
Q1
$828K Buy
+3,845
New +$808K 0.11% 164
2023
Q1
Sell
-71
Closed -$11.9K 420
2022
Q4
$11.9K Buy
+71
New +$12.3K ﹤0.01% 705

Other funds holding CME

Romano Brothers & Co's CME Position: Q2 2026 in Review

Romano Brothers & Co increased its CME Group (CME) stake by 0.95% in Q2 2026, buying an estimated $2.49K and bringing the position to 954 shares worth $211K. The position accounts for 0.02% of the portfolio, ranked #327.

Romano Brothers & Co first reported a position in CME in Q4 2022 and has held it in 10 quarters since. The position peaked at $828K in Q1 2024. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Romano Brothers & Co held 954 shares of CME Group worth $211K as of Q2 2026.
  • Romano Brothers & Co bought 9 CME Group shares in Q2 2026, an estimated $2.49K.
  • CME Group made up 0.02% of Romano Brothers & Co's portfolio in Q2 2026, its #327 holding.
  • Romano Brothers & Co first reported a position in CME Group in Q4 2022 and has held it in 10 quarters since.
  • Romano Brothers & Co's CME Group position peaked at $828K in Q1 2024.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Romano Brothers & Co's 13F filing for Q2 2026, filed 22 Jul 2026.